FDA approval of update to the label of Qelbree (viloxazine extended-release capsules) to include new pharmacodynamic data – Supernus Pharma
Supernus Pharmaceuticals, Inc .announced that the FDA has approved an update for the label for Qelbree (viloxazine extended-release capsules) to include new pharmacodynamic data in Section 12.2. The… read more.